(NP (NP (NNS Objectives)) (: :) (S (NP (JJS Most) (NN cancer) (NNS data) (NNS sources)) (VP (VBP lack) (NP (NP (NN information)) (PP (IN on) (NP (JJ metastatic) (NN recurrence)))))) (. .))
(S (NP (NP (NP (NNP Electronic) (JJ medical) (NNS records)) (PRN (-LRB- -LRB-) (NP (NNP EMRs)) (-RRB- -RRB-))) (CC and) (NP (JJ population-based) (NN cancer) (NNS registries))) (VP (VP (VBP contain) (NP (NP (JJ complementary) (NN information)) (PP (IN on) (NP (NN cancer) (NN treatment) (CC and) (NNS outcomes))))) (, ,) (CC yet) (VP (VBP are) (ADVP (RB rarely)) (VP (VBN used) (ADVP (RB synergistically))))) (. .))
(S (S (VP (TO To) (VP (VB enable) (NP (NP (NN detection)) (PP (IN of) (NP (NP (JJ metastatic) (NN breast) (NN cancer)) (PRN (-LRB- -LRB-) (NP (NNP MBC)) (-RRB- -RRB-)))))))) (, ,) (NP (PRP we)) (VP (VBD applied) (NP (DT a) (JJ semi-supervised) (NN machine) (VBG learning) (NN framework)) (PP (TO to) (NP (VBN linked) (NNP EMR-California) (NNP Cancer) (NNP Registry) (PRN (-LRB- -LRB-) (NNP CCR) (-RRB- -RRB-)) (NN data)))) (. .))
(NP (NP (NNS Materials) (CC and) (NNS Methods)) (: :) (S (NP (PRP We)) (VP (VBD studied) (NP (NP (CD 11,459) (JJ female) (NNS patients)) (VP (VBN treated) (PP (IN at) (NP (NNP Stanford) (NNP Health) (NNP Care)))) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (DT an) (JJ incident) (NN breast) (NN cancer) (NN diagnosis)) (PP (IN from) (NP (JJ 2000-2014))))))))) (. .))
(S (NP (DT The) (NN dataset)) (VP (VBD consisted) (PP (IN of) (NP (NP (NP (NP (VBN structured) (NNS data)) (CC and) (NP (JJ unstructured) (JJ free-text) (JJ clinical) (NNS notes))) (PP (IN from) (NP (NNP EMR)))) (, ,) (VP (VBD linked) (PP (TO to) (NP (NP (NNP CCR)) (, ,) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (DT the) (NNP Surveillance) (, ,) (NNP Epidemiology) (CC and) (NNP End) (NNP Results) (PRN (-LRB- -LRB-) (NP (NNP SEER)) (-RRB- -RRB-)) (NN database)))))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBD extracted) (NP (NP (NN information)) (PP (IN on) (NP (JJ metastatic) (NN disease)))) (PP (IN from) (NP (JJ patient) (NNS notes))) (S (VP (TO to) (VP (VB infer) (NP (DT a) (NN class) (NN label)))))) (CC and) (ADVP (RB then)) (VP (VBD trained) (NP (DT a) (VBN regularized) (JJ logistic) (NN regression) (NN model)) (PP (IN for) (NP (NNP MBC) (NN classification))))) (. .))
(S (NP (PRP We)) (VP (VBD evaluated) (NP (NN model) (NN performance)) (PP (IN on) (NP (NP (DT a) (JJ gold) (NN standard) (NN set)) (PP (IN of) (NP (NP (NN set)) (PP (IN of) (NP (CD 146) (NNS patients)))))))) (. .))
(NP (NP (NNS Results)) (: :) (S (S (NP (EX There)) (VP (VBP are) (NP (NP (CD 495) (NNS patients)) (PP (IN with) (NP (ADJP (FW de) (FW novo)) (NN stage) (NNP IV) (NNP MBC)))))) (, ,) (S (NP (NP (CD 1,374) (NNS patients)) (VP (ADVP (RB initially)) (VBN diagnosed) (PP (IN with) (NP (NNP Stage) (JJ 0-III) (NN disease))))) (VP (VBD had) (NP (JJ recurrent) (NNP MBC)))) (, ,) (CC and) (S (NP (CD 9,590)) (VP (VBD had) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NN metastatis))))))) (. .))
(S (NP (DT The) (JJ median) (JJ follow-up) (NN time)) (VP (VBZ is) (NP (CD 96.3) (NNS months)) (PRN (-LRB- -LRB-) (NP (NP (NP (JJ mean)) (NP (CD 97.8))) (, ,) (NP (NP (JJ standard) (NN deviation)) (NP (CD 46.7)))) (-RRB- -RRB-))) (. .))
(S (NP (DT The) (JJ best-performing) (NN model)) (VP (VBN incorporated) (NP (DT both) (NNP EMR) (CC and) (NNP CCR) (NNS features))) (. .))
(S (S (NP (NX (S (VP (NP (DT The) (NN area)) (IN under)))) (NP (DT the) (JJ receiver-operating) (JJ characteristic) (NN curve=0.925))) (PRN (VBD -LSB-) (NP (NP (ADJP (CD 95) (NN %)) (NN confidence) (NN interval)) (: :) (NP (JJ 0.880-0.969))) (NN -RSB-))) (, ,) (NP (NN sensitivity=0.861)) (, ,) (NP (NN specificity=0.878)) (CC and) (S (JJ overall) (NN accuracy=0.870)) (. .))
(NP (NP (NN Discussion) (CC and) (NN Conclusion)) (: :) (S (NP (NP (DT A) (NN framework)) (PP (IN for) (NP (NNP MBC) (NN case) (NN detection))) (VP (VBG combining) (NP (NNP EMR) (CC and) (NNP CCR) (NNS data)))) (VP (VBD achieved) (NP (JJ good) (NN sensitivity) (, ,) (NN specificity) (CC and) (NN discrimination)) (PP (IN without) (S (VP (VBG requiring) (NP (JJ expert-labeled) (NNS examples))))))) (. .))
(S (NP (DT This) (NN approach)) (VP (VP (VBZ enables) (NP (NP (JJ population-based) (NN research)) (PP (IN on) (SBAR (WHADVP (WRB how)) (S (NP (NNS patients)) (VP (VBP die) (PP (IN from) (NP (NN cancer))))))))) (CC and) (VP (MD may) (VP (VB identify) (NP (NP (JJ novel) (NNS predictors)) (PP (IN of) (NP (NN cancer) (NN recurrence))))))) (. .))
